Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Monash Health, Melbourne, Australia

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · +44 (0)1223 348 454
    Contact: Principal Investigator (Dan Croagh)
  • Epworth Healthcare, Richmond, Australia

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · +44 (0)1223 348 454
    Contact: Principal Investigator (Sumitra Ananda)
  • Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · 01223348454
    Contact: Principal Investigator (Bristi Basu)
  • Glan Clwyd Hospital, Bodelwyddan, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · +44 (0)1223 348 454
    Contact: Principal Investigator (Angel Garcia)
  • Velindre Cancer Centre, Cardiff, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · 01223 348454
    Contact: Principal Investigator (Seema Arif)
  • University Hospitals Coventry and Warwickshire, Coventry, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Martin Scott-Brown)
  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Fieke Froeling)
  • St James' University Hospital, Leeds, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Alan Anthoney)
  • Clatterbridge Cancer Centre, Liverpool, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · +44 (0)1223 348 454
    Contact: Principal Investigator (Daniel Palmer)
  • Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Debashis Sarker)
  • Royal Free Hospital, London, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Roopinder Gillmore)
  • University College London Hospitals NHS Foundation Trust, London, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (John Bridgewater)
  • The Christie, Manchester, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Mairead McNamara)
  • Milton Keynes University Hospital, Milton Keynes, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Wasiru Saka)
  • Norfolk and Norwich University Hospital, Norwich, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Daniel Holyoake)
  • Nottingham University Hospitals NHS Foundation Trust, Nottingham, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net · +44 01223 348454
    Contact: Principal Investigator (Arvind Arora)
  • Derriford Hospital, Plymouth, United Kingdom

    Contact: Study coordinator (Clinical Trial Coordinator) · cuh.pemola@nhs.net
    Contact: Principal Investigator (Dominique Parslow)
Study leads
  • Pippa Corrie

    Principal Investigator

    Cambridge University Hospital